KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,572,187 | -32.9% | 50,696 | -13.9% | 0.01% | -36.4% |
| Q2 2023 | $12,766,610 | +29.1% | 58,873 | +8.1% | 0.01% | +22.2% |
| Q1 2023 | $9,891,025 | +11.1% | 54,454 | +20.1% | 0.01% | +12.5% |
| Q4 2022 | $8,906,559 | -11.0% | 45,326 | +1.8% | 0.01% | -11.1% |
| Q3 2022 | $10,011,000 | +159.4% | 44,508 | +38.7% | 0.01% | +200.0% |
| Q1 2021 | $3,859,000 | +18.3% | 32,100 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $3,261,000 | +18.1% | 32,100 | -10.2% | 0.00% | +50.0% |
| Q3 2020 | $2,762,000 | -27.8% | 35,728 | +4.1% | 0.00% | -50.0% |
| Q2 2020 | $3,826,000 | +264.4% | 34,328 | +135.3% | 0.00% | +300.0% |
| Q1 2020 | $1,050,000 | +23.4% | 14,589 | +29.2% | 0.00% | 0.0% |
| Q4 2019 | $851,000 | – | 11,289 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |